Publications by authors named "Stefanos Labropoulos"

Claim this Profile
T
The Value of New Fields in the Medical Record for Quality Improvement.
Theodore Poufos, Georgios Rigakos, Stefanos Labropoulos, Kalliopi Stathaki, Ioanna Theodorakopoulou

Glob J Qual Saf Healthc· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is There an Independent Role of TERT and NF1 in High Grade Gliomas?
Evangelia Razis, Vassiliki Kotoula, Georgia-Angeliki Koliou, Kyriaki Papadopoulou, Eleni Vrettou, Stefanos V Labropoulos

Transl Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical Femoral Fractures (AFF) from Bone Remodeling Agents in Patients with Cancer.
Maria Kordoni, Georgios Rigakos, Young Hun Minjoo Kim, Loukas Kaklamanis, Ourania Nikolatou-Galitis, Stefanos Labropoulos

Anticancer Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Periodontal disease preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving antiresorptives alone or combined with targeted therapies: report of 5 cases and literature review.
Ourania Nicolatou-Galitis, Evangelia Razis, Dimitra Galiti, Evangelos Galitis, Stefanos Labropoulos

Oral Surg Oral Med Oral Pathol Oral Radiol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MBD2 contributes to developmental silencing of the human ε-globin gene.
Jeremy W Rupon, Shou Zhen Wang, Merlin Gnanapragasam, Stefanos Labropoulos, Gordon D Ginder

Blood Cells Mol Dis· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elucidation of the transmission of a novel mutation in BRCA1 (1125delCT) in a family with multiple cases of breast cancer.
Evangelia Razis, Ioulia Belogianni, Vagia Siamanta, Angela Apessos, Vanessa Kyriakopoulou, Stefanos Labropoulos

Cancer Genomics Proteomics· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib in the treatment of dermatofibrosarcoma protuberans.
Stefanos V Labropoulos, Evangelia D Razis

Biologics· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational and methylation analysis of the cyclin-dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia.
Panagiotis Tsirigotis, Vassiliki Pappa, Stefanos Labropoulos, Sotirios Papageorgiou, Frinda Kontsioti

Eur J Haematol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained complete remission of metastatic dermatofibrosarcoma protuberans with imatinib mesylate.
Stefanos V Labropoulos, Jonathan A Fletcher, Andre M Oliveira, Savvas Papadopoulos, Evangelia D Razis

Anticancer Drugs· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a novel large deletion and single point mutations in the BRCA1 gene in a Greek cohort of families with suspected hereditary breast cancer.
Ioulia Belogianni, Angela Apessos, Markos Mihalatos, Evangelia Razi, Stefanos Labropoulos

BMC Cancer· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuation of trastuzumab beyond disease progression is feasible and safe in patients with metastatic breast cancer: a retrospective analysis of 80 cases by the hellenic cooperative oncology group.
George Fountzilas, Evangelia Razis, Dimitrios Tsavdaridis, Maria Karina, Stefanos Labropoulos

Clin Breast Cancer· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis